Cryo Cell International CCEL Ratios (2010-2026)

NYSE CCEL
$4.65 +0.00 (+0.00%)
As of: Oct 20, 2026 · 3:21 PM EDT
Reported Financials

Cryo Cell International Quarterly Ratios

Periods 65 quarters
Latest Aug 2026

Cryo Cell International reported a gross margin of 79.38% and a net margin of 16.24% for the quarter ended Aug 2026. These financial ratios cover 65 quarters of results from Aug 2010 through Aug 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026 Aug2026
Profitability
Gross Margin
68.62%71.02%71.16%69.42%72.45%73.58%72.43%72.60%74.31%73.68%74.83%73.65%79.60%75.10%76.58%76.98%77.89%78.44%78.44%79.38%
EBT Margin
-17.00%15.92%11.79%8.34%8.02%15.52%4.46%13.57%-203.04%10.12%18.30%17.11%-10.50%6.70%7.25%15.16%-59.06%0.92%10.65%23.33%
EBIT Margin
-11.05%20.26%15.65%12.42%5.22%21.51%13.22%14.75%-205.37%10.46%17.30%17.23%-1.52%13.25%18.83%24.29%-50.58%9.96%15.40%28.04%
EBITDA Margin
-6.45%25.80%20.47%17.24%10.05%26.31%17.86%19.13%-201.03%11.62%18.76%20.35%1.64%16.43%22.05%27.47%-47.41%13.20%18.60%31.18%
Operating Margin
-11.05%20.26%15.65%12.42%5.22%21.51%13.22%14.75%-205.37%10.46%17.30%17.23%-1.52%13.25%18.83%24.29%-50.58%9.96%15.40%28.04%
Net Margin
-8.71%11.46%8.32%6.08%10.79%9.80%2.84%8.65%-142.06%7.08%8.15%13.04%-23.20%3.55%4.49%9.58%-48.67%0.61%7.13%16.24%
FCF Margin
18.97%11.84%21.49%-111.31%31.62%16.21%6.84%-17.14%20.69%-10.37%0.27%27.91%26.78%11.19%8.13%31.92%15.47%7.61%23.32%13.29%
Efficiency
Inventory AverageInventory Avg.
0.88M0.92M0.90M0.90M0.89M0.88M0.89M0.97M0.92M0.76M0.73M0.72M0.69M0.69M0.70M0.67M0.53M0.38M0.33M0.42M
Assets AverageAssets Avg.
60.04M57.74M55.10M61.08M65.83M65.51M67.45M69.28M67.24M63.19M62.14M62.75M63.81M64.53M64.41M63.80M62.45M61.31M60.80M61.50M
Equity AverageEquity Avg.
4.49M4.22M4.33M1.01M-1.95M-1.11M-0.77M-0.44M-5.52M-10.68M-10.54M-10.15M-11.39M-13.94M-15.11M-15.20M-16.72M-18.50M-18.08M-17.08M
Invested CapitalInvested Cap.
6.96M6.26M5.64M7.25M10.35M10.67M10.45M12.21M-0.34M1.07M2.88M2.04M-0.34M-0.76M0.35M-2.37M-7.08M-7.61M-8.61M-7.28M
Asset Utilization RatioAsset Util.
0.480.510.540.490.460.470.460.450.470.500.510.510.500.500.500.500.510.510.510.51
Leverage & Solvency
Interest Coverage RatioInterest Cover
-1.924.804.322.610.713.612.192.47-95.703.204.232.61-0.162.132.713.53-8.231.652.715.01
Debt Ratio
0.050.040.020.140.180.170.160.180.170.180.220.180.200.220.250.200.190.180.150.15
Times Interest Earned
-1.924.804.322.610.713.612.192.47-95.703.204.232.61-0.162.132.713.53-8.231.652.715.01
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
-0.920.140.29
FCF Payout RatioFCF Cover
0.942.271.88
Dividend YieldDiv. Yield
2.88%6.33%12.72%13.87%9.33%4.42%
Payout Ratio
5.0331.40
Valuation
Price to EarningsP/E
50.8531.0730.5448.4713.4011.9217.5319.84174.27496.07
Price to SalesP/S
3.672.361.732.101.221.041.291.591.411.372.091.572.191.991.291.191.100.880.871.09
Price to BookP/B
25.3216.2411.68
Enterprise Value
97.60M66.41M48.62M59.87M35.43M30.04M38.50M48.51M43.35M41.95M64.75M47.86M66.58M60.37M36.86M34.64M31.34M24.49M24.01M29.63M
EV to EBIT
24.2915.6114.0821.308.807.099.4611.3419.1316.259.668.0164.97127.86156.45
EV to EBITDA
19.0811.839.9413.966.405.256.948.4615.8713.157.636.4921.0620.5126.9225.09
Market Capitalization
105.94M69.03M51.49M62.83M37.15M32.25M40.19M49.72M44.33M42.93M66.28M49.99M70.07M63.85M41.29M37.86M34.64M27.39M27.17M33.86M
Price to FCFP/FCF
17.3916.0511.6617.1121.3116.1919.4312.026.956.126.605.544.457.28
EV to FCF
16.0215.4411.0116.6920.8415.5018.4611.366.215.605.974.963.936.37
EV to CFO
12.319.816.777.674.133.454.406.064.866.069.666.6511.088.255.895.455.724.733.806.02
Return Ratios
Return on Sales [ROS]ROS
-11.05%20.26%15.65%12.42%5.22%21.51%13.22%14.75%-205.37%10.46%17.30%17.23%-1.52%13.25%18.83%24.29%-50.58%9.96%15.40%28.04%
Return on Capital Employed [ROCE]ROCE
10.31%10.29%8.77%7.50%8.68%9.09%8.53%8.43%-26.53%-30.04%-29.99%-27.74%8.25%8.68%8.95%9.54%1.13%0.44%-0.23%0.41%
Return on Invested Capital [ROIC]ROIC
41.93%50.83%47.21%38.91%38.17%32.30%31.29%29.10%-147.64%-2,538.89%-475.54%-368.89%58.59%
Return on Assets [ROA]ROA
3.47%3.85%3.06%2.12%4.21%4.13%3.40%3.62%-14.16%-15.40%-14.96%-14.23%0.63%0.20%-0.27%-0.74%-3.89%-4.35%-4.06%-3.16%
Return on Equity [ROE]ROE
46.39%52.68%38.95%128.26%

Cryo Cell International Ratios API

Pull Cryo Cell International's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CCEL&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY